December 06, 1999 - 2:38 p.m.
Gilead Sciences Announces Changes to Senior Management Team
Printer Friendly Version 
December 03, 1999 - 2:34 p.m.
Gilead Sciences Announces Termination of Its U.S. Development Program for Adefovir Dipivoxil for HIV
Printer Friendly Version 
November 30, 1999 - 2:33 p.m.
Gilead Begins Multinational Phase III Trial of Once Daily Oral Anti-HIV Drug, Tenofovir Disoproxil Fumarate
Printer Friendly Version 
November 08, 1999 - 11:21 a.m.
Roche Announces New Data on Recently Approved Tamiflu™, First Pill to Treat the Most Common Strains of Influenza (A & B)
Printer Friendly Version 
November 01, 1999 - 11:19 a.m.
Gilead Sciences Announces Results of FDA Advisory Panel on Anti-HIV Agent, Adefovir Dipivoxil 60 Mg
Printer Friendly Version 
October 27, 1999 - 11:15 a.m.
Roche Receives FDA Approval Of TAMIFLU™, First Pill To Treat The Most Common Strains Of Influenza (A&B)
Printer Friendly Version 
October 27, 1999 - 10:56 a.m.
Gilead Announces Third Quarter 1999 Financial Results
Printer Friendly Version 
October 27, 1999 - 10:34 a.m.
1999 Third Quarter Highlights
Printer Friendly Version 
October 25, 1999 - 9:44 a.m.
Gilead Sciences Completes European Marketing Authorisation Application For Anti-HIV Agent Adefovir Dipivoxil 60 Mg
Printer Friendly Version 
October 22, 1999 - 9:42 a.m.
Gilead Sciences Amends Stockholder Rights Plan
Printer Friendly Version 
September 27, 1999 - 6:48 p.m.
AmBisome® Phase III Study For Cryptococcal Meningitis
Printer Friendly Version 
September 27, 1999 - 6:38 p.m.
Preliminary Phase II Clinical Results For Once-Daily Anti-HIV Agent, Tenofovir DF, Presented At ICAAC
Printer Friendly Version 
September 24, 1999 - 6:24 p.m.
First Approval of Roche’s Tamiflu™, a New Flu Treatment
Printer Friendly Version 
September 13, 1999 - 6:22 p.m.
Gilead Sciences Announces Acceptance Of Late Breaker Abstract At Upcoming Scientific Conference
Printer Friendly Version 
July 29, 1999 - 6:06 p.m.
Gilead Acquisition Of NeXstar Completed
Printer Friendly Version 
July 29, 1999 - 5:57 p.m.
Gilead Announces Second Quarter 1999 Financial Results
Printer Friendly Version 
June 24, 1999 - 5:50 p.m.
Gilead Sciences and NeXstar Pharmaceuticals Announce Date for Special Stockholders Meetings to Approve Merger
Printer Friendly Version 
April 29, 1999 - 5:38 p.m.
Hoffmann-La Roche Submits New Drug Application to Market New Flu Pill
Printer Friendly Version 
April 29, 1999 - 5:27 p.m.
Gilead Announces First Quarter 1999 Financial Results
Printer Friendly Version 
April 09, 1999 - 5:18 p.m.
Gilead Presents Preliminary Clinical Data Demonstrating Activity of Adefovir Dipivoxil Against Lamivudine-Resistant Hepatitis B Virus
Printer Friendly Version 
March 17, 1999 - 5:11 p.m.
Gilead Begins Multinational Phase III Trial of Hepatitis B Drug, Adefovir Dipivoxil
Printer Friendly Version 
March 01, 1999 - 5:03 p.m.
Gilead Sciences and NeXstar Pharmaceuticals to Merge
Printer Friendly Version 
January 27, 1999 - 4:51 p.m.
Gilead Announces Fourth Quarter and 1998 Year-End Financial Results
Printer Friendly Version 
NASDAQ (US Dollar)
$82.62
 Stock is Down 0.02 (0.02%)
Data as of 09/21/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh Quote